日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Biological markers of disease activity in inflammatory bowel diseases

炎症性肠病疾病活动的生物标志物

Szymanska, Edyta; Szymanska, Sylwia; Dadalski, Maciej; Kierkus, Jaroslaw

Chronic inflammatory bowel diseases and sexuality: Inevitable disorders?

慢性炎症性肠病与性生活:不可避免的疾病?

Wiernicka, Anna; Szymanska, Sylwia; Cielecka-Kuszyk, Joanna; Dadalski, Maciej; Kierkus, Jaroslaw; Vanzetto, S; Vismara, M; Frediani, A; Cassina, N; Maconi, G; Bosi, M; Viganò, C; Dell’Osso, B; Charfi, N; Guermazi, A; Guermazi, F; Omri, S; Smaoui, N; Feki, R; Thabet, J Ben; Zouari, L; Bouali, M Maalej; Tahri, N; Boudabous, M; Maalej, M

Premedication Does Not Influence the Incidence of Infliximab Infusion Reactions in Pediatric Patients with Inflammatory Bowel Disease-A Single Center Case-Control Study

预先用药不影响儿童炎症性肠病患者英夫利昔单抗输注反应的发生率——一项单中心病例对照研究

Szymanska, Edyta; Dadalski, Maciej; Sieczkowska-Golub, Joanna; Jarzebicka, Dorota; Meglicka, Monika; Osiecki, Marcin; Wiernicka, Anna; Lebensztejn, Dariusz M; Korczowski, Bartosz; Kierkus, Jaroslaw

Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn's disease

阿达木单抗用于治疗中重度克罗恩病患儿的内镜和组织病理学黏膜愈合

Szymanska, Edyta; Dadalski, Maciej; Grajkowska, Wieslawa; Szymanska, Sylwia; Pronicki, Maciej; Kierkus, Jaroslaw

The impact of induction therapy with three doses of infliximab on deep histological healing in paediatric patients with active Crohn's disease

英夫利昔单抗三剂诱导治疗对活动性克罗恩病患儿深层组织学愈合的影响

Szymanska, Edyta; Dadalski, Maciej; Szymanska, Sylwia; Grajkowska, Wieslawa; Pronicki, Maciej; Kierkus, Jaroslaw

Safety profile of biologic therapy in Polish paediatric patients with Crohn's disease

波兰克罗恩病患儿生物疗法的安全性概况

Szymanska, Edyta; Dadalski, Maciej; Oracz, Grzegorz; Kierkus, Jarosław